When the MET receptor kicks in to resist targeted therapies
Marie Fernandes, Philippe Jamme, Alexis B. Cortot, Zoulika Kherrouche, David Tulasne
Topics & Concepts
DruggabilityBiologyReceptor tyrosine kinaseTargeted therapyCancer researchReceptor Protein-Tyrosine KinasesSignal transductionTyrosine kinaseCabozantinibReceptorBioinformaticsCancerGeneticsGeneVEGF receptorsPI3K/AKT/mTOR signaling in cancerCancer Mechanisms and TherapyLung Cancer Treatments and Mutations